A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation.
Rao, Satish MD 1; Lembo, Anthony J MD 2; Shiff, Steven J MD 3; Lavins, Bernard J MD 4; Currie, Mark G PhD 4; Jia, Xinwei D PhD 3; Shi, Kelvin PhD 3; MacDougall, James E PhD 4; Shao, James Z MS 4; Eng, Paul PhD 3; Fox, Susan M PhD 3; Schneier, Harvey A MD 3; Kurtz, Caroline B PhD 4; Johnston, Jeffrey M MD 4
American Journal of Gastroenterology.
107(11):1714-1724, November 2012.
(Format: HTML, PDF)